How new diagnostic pathways can support earlier diagnosis and appropriate management in patients with lower gastrointestinal ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.

I had a symptom of colon cancer and family history, so I got a colonoscopy. It was expensive, and insurance was a nightmare, ...

Dr Ray O’Connor takes a look at the latest clinical articles on gastrointestinal cancers – which comprise more than ...

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Though extremely rare, cancers of the appendix are being diagnosed at higher rates in Gen X and millennials compared with earlier cohorts.

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Cancer is often linked to old age. Many people think it happens late in life. But a quiet shift is happening now, especially with cancers in your stomach and bowels. It isn’t just an old person’s ...

Jenna Scott said doctors chalked up her abdominal cramping to pregnancy symptoms or IBS. It took a year to get diagnosed with ...